Characterization of the biological role of murine erythroleukemia cells "differentiation enhancing factor" using antisense oligodeoxynucleotides

Biochem Biophys Res Commun. 1993 Jun 30;193(3):941-7. doi: 10.1006/bbrc.1993.1716.

Abstract

On the basis of the amino acid sequence of isolated tryptic peptides, it has been established that the differentiation enhancing factor, produced and active on murine erythroleukemia (MEL) cells, possesses a unique sequence, with no similarity to that of known proteins. Accordingly, this factor can be defined as a novel biologically active peptide. An antisense oligodeoxynucleotide, deduced from the sequence of a non-decapeptide (produced by tryptic digestion of the factor), decreases the rate and the extent of MEL cell differentiation, induced by hexamethylenebisacetamide. In these cells the amount of the factor is reduced to one third of that constitutively present in untreated cells. Exogenous addition of the factor restores cell inducibility to normal values. Taken together, these results demonstrate the presence in MEL cells of a new factor, structurally and functionally unrelated to any of the known biologically active peptides, and suggest its crucial role in the promotion of an initial signal, in chemically induced erythroid differentiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Cell Differentiation / drug effects*
  • Drug Resistance
  • HMGB1 Protein*
  • Leukemia, Erythroblastic, Acute
  • Leukemia, Experimental
  • Mice
  • Molecular Sequence Data
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / physiology*
  • Oligonucleotides, Antisense / pharmacology*
  • Tumor Cells, Cultured
  • Vincristine / toxicity

Substances

  • HMGB1 Protein
  • Neoplasm Proteins
  • Oligonucleotides, Antisense
  • Vincristine